JACC

The American College of Cardiology Renews its Publishing Partnership With Elsevier

...ng term partnership. Elsevier has published jacc since its inception in 1983. Published weekly, jacc has the highest readership (according to PERQ/HCI ...d highest impact factor (11.054) in its specialty. jacc articles were cited nearly 53,000 times in 2007 an...

New appropriate use criteria guide treatment of patients with heart blockage

...opriate Use Criteria for Coronary Revascularization," appears in the February 10, 2009, issue of the Journal of the American College of Cardiology ( jacc ) and online at www.acc.org . The document will also be published in the January 5, 2009, online issues of Catheterization and Cardiovascular Interve...

Breast cancer awareness calls for cardiovascular awareness

.... There are millions of American women living with breast cancer, said Pamela S. Douglas, M.D., chief of cardiology at Duke and a co-author of the jacc paper. Its important that they dont squander their second lease on life. Breast cancer is the most common form of cancer among American women, acc...

New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function

...ic cocoa on blood vessel function to be one of the major advancements in cardiovascular research in 2005. (DeMaria AN et al. Highlights of the Year in jacc 2005. Journal of the American College of Cardiology. 2006; 47:184-202.) Working in collaboration with top research institutions throughout the wor...

JACC in Medical Technology

CryoCath Arctic Front(R) Results Published in JACC

- Strong efficacy results from a multi-center 293-patient European trial - http://www.cryocath.com Toronto Stock Exchange Symbol: CYT MONTREAL, July 22 /PRNewswire-FirstCall/ - CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, toda...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

... of this independent study was to evaluate restenosis rates of drug-eluting stents in patients with and without diabetes in a real-world setting. The jacc article reported that both the TAXUS Liberte Stent and Boston Scientific's first-generation DES -- the TAXUS(R) Express(R) Stent -- were the only sten...

JACC Identifies DEFER with 5-year Outcomes as Landmark Trial

...ear that the key issue in deciding which lesions should be stented is knowledge about whether a stenosis is responsible for ischemia. We are glad that jacc has recognized this study that demonstrates the importance of FFR and its role in interventional cardiology." FFR expresses maximum achievable blood...

Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology

...(1) paclitaxel-eluting stent system. The article in the April 24 edition of jacc concluded that the shorter procedure time and lower bailout rate of the TAX... co-principal investigator of the TAXUS ATLAS trial. Data reported in the jacc article showed the TAXUS Liberte Stent was associated with significantly sh...

JACC in Biological Technology

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...onstrated a statistically significant lower restenosis rate compared to the Endeavor, which had more than two times the risk of repeat procedures. The jacc article reported that both the TAXUS Liberte stent and BSC's first-generation paclitaxel-eluting stent, the TAXUS Express, were the only stents in the...